Health Products

INRatio/INRatio 2 Prothrombin Time (PT) Monitoring Systems and Test Strips (2016-07-12)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
All lots
Manufacturer
Alere San Diego, Inc.
9975 Summers Ridge Road
San Diego
92121
California
UNITED STATES
B. INRATIO 2 PROTHROMBIN TIME (PT) MONITORING SYSTEM, PROFESSIONAL200431
All lots
Manufacturer
Alere San Diego, Inc.
9975 Summers Ridge Road
San Diego
92121
California
UNITED STATES
C. INRATIO/INRATIO 2 PROTHROMBIN TIME/INR TEST STRIPS0100071
All lots
Manufacturer
Alere San Diego, Inc.
9975 Summers Ridge Road
San Diego
92121
California
UNITED STATES
A. INRATIO 2 PROTHROMBIN TIME (PT) MONITORING SYSTEM, SELF-TEST200433

Introduction

 Affected products
  1. INRATIO 2 PROTHROMBIN TIME (PT) MONITORING SYSTEM, SELF-TEST
  2. INRATIO 2 PROTHROMBIN TIME (PT) MONITORING SYSTEM, PROFESSIONAL
  3. INRATIO/INRATIO 2 PROTHROMBIN TIME/INR TEST STRIPS

Reason

Alere is withdrawing the Alere INRatio and INRatio 2 prothrombin time (PT) monitoring systems (professional use and patient self-test) devices from the Canadian market. There is a risk, in certain cases, that the Alere devices provide an inaccurate low reading. Alere, with the best interest of patient safety in mind, has decided to voluntarily remove the Alere INRatio system from the market and to discontinue manufacturing the product line. Alere will continue manufacturing and distributing the INRatio test strips for a period of time to allow patients to safely transition to another monitoring method. Alere advises that users of the INRatio system transition, as soon as possible, to an alternate method to perform PT/INR testing, such as a plasma-based laboratory INR or a point of care monitoring system from a different manufacturer. Until such time that a facility has transitioned to an alternate method of PT/INR testing, they may continue to use the Alere INRatio system as long as they ensure that the facility and their patients (either patients being tested at their facility or their patients who self-test at home) adhere to the precautions and recommendations found in the medical device correction notification of December 2014 and current product insert labeling. These are available at www.inr-care.com or by calling Alere at 1-877-866-5313.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime